直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Issue Preclusion Can Apply to Prior Inter Partes Reexamination Determinations

March 4, 2021

Authored and Edited by Eric S Magleby; Sydney R. Kestle; Elizabeth D. Ferrill

In SynQor, Inc. v. Vicor Corp., No. 2019-1704 (Fed. Cir. Feb. 22, 2021), a panel majority found that issue preclusion could apply to prior inter partes reexamination determinations, and that, in view of issue preclusion, the PTAB erred in holding unpatentable claims involved in a later inter partes reexamination. Judge Dyk dissented.

In 2011, SynQor asserted several patents against Vicor, including U.S. Patent 7,564,702 (’702 patent), 8,023,290 (’290 patent), and 7,072,190 (’190 patent), which are part of the same family. Vicor requested inter partes reexamination of all three, asserting that their claims were obvious in view of two references: Steigerwald and Cobos. In the ’702 and ’290 proceedings, the claims were held not unpatentable. The PTAB reasoned that Steigerwald and Cobos disclosed circuits operating at incompatible frequencies and their disclosures would not have been combined by a POSA. These determinations were affirmed by the Federal Circuit in earlier appeals. In the ’190 proceeding, the PTAB came to the opposite conclusion: Steigerwald and Cobos did not disclose incompatible frequencies, and the ’190 patent claims were unpatentable. SynQor appealed from that determination.

The panel majority vacated the PTAB’s determination in the ’190 proceeding. It first reasoned that the statutory scheme governing inter partes reexaminations showed no intent to foreclose issue preclusion. It then found the procedural mechanisms used in inter partes reexaminations, including the participation of the requester to provide both argument and evidence, made inter partes reexaminations sufficiently “adversarial” to justify the application of issue preclusion. In applying issue preclusion, the panel majority found that the PTAB’s earlier determination that a POSA would not have combined Steigerwald and Cobos had preclusive effect, and the PTAB could not come to a different conclusion in the ’190 proceeding.

Judge Dyk dissented. In his view, issue preclusion does not apply to inter partes reexaminations because they “are examinational (or inquisitorial) rather than adjudicatory, do not include court-like adjudicatory procedures, and do not satisfy the requirements in B&B Hardware, Inc. . . . for application of collateral estoppel.” Judge Dyk found “of critical importance” the lack of the “third-party requester’s ability to cross-examine the witness.”

Tags

Patent Trial and Appeal Board (PTAB), United States Court of Appeals for the Federal Circuit (CAFC), patentability, Obviousness (35 USC § 103), preclusion, collateral estoppel

For more information

  • Synqor, Inc. v. Vicor Corporation

Related Practices

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Industries

Chemicals, Industrials, and Materials

Manufacturing

Related Offices

Washington, DC

Contacts

Sydney R. Kestle
Partner
Washington, DC
+1 202 408 4241
Email
Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2021 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Charitable

Banding Together 2026

June 18, 2026

Washington, DC

Articles

California Reaches Record $12.75 Million CCPA Settlement with General Motors Over Driver Data

June 4, 2026

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP